Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adult Solid Neoplasm × pegfilgrastim × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Hodgkin Disease 3 Triple Negative Breast Neoplasms 2 Burkitt Lymphoma 2 Teratoma 1 Sleep Initiation and Maintenance Disorders 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosarcoma 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, AIDS-Related 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Inflammatory Breast Neoplasms 1 Infiltrating Bladder Urothelial Carcinoma 1 Hematologic Neoplasms 1 Glioma 1 Fatigue 1 Desmoplastic Small Round Cell Tumor 1 Depression 1 Choriocarcinoma 1 Central Nervous System Neoplasms 1

Interventions

temsirolimus 1 ixabepilone 1 Sirolimus 1 Irinotecan 1 Erlotinib Hydrochloride 1 Epothilones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡